Showing results (1-10 of 367) with videos related to
Sort By:
Pageof 37
Expert Opinion on Pharmacotherapy|December 4, 2003
Merkel cell carcinoma--current therapeutic optionsMichael Poulsen, Danny RischinInternational Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skinMichael Poulsen, Euan Walpole, Jennifer Harvey, et al.International Journal of Radiation Oncology, Biology, Physics|January 8, 2013
The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma--a TROG substudyRenee Finnigan, George Hruby, Chris Wratten, et al.Seminars in Oncology|December 16, 2004
Strategies to overcome accelerated repopulation and hypoxia--what have we learned from clinical trials?June Corry, Danny RischinHematology/Oncology Clinics of North America|November 18, 2008
Sinonasal malignancies of neuroendocrine originDanny Rischin, Andrew ColemanJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07Michael Poulsen, Danny Rischin, Euan Walpole, et al.Journal of Medical Imaging and Radiation Oncology|February 7, 2018
Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03Michael Poulsen, David Macfarlane, Michael Veness, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Merkel cell carcinoma: emerging biology, current approaches, and future directionsRichard Tothill, Vanessa Estall, Danny RischinCancer|March 1, 2014
What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Damien Urban, June Corry, Danny RischinThe Lancet. Oncology|March 6, 2010
Optimising the therapeutic ratio in head and neck cancerJune Corry, Lester J Peters, Danny RischinPageof 37